Opportunity Information: Apply for PA 16 283
Apply for PA 16 283
- The HHS-AHRQ in the health sector is offering a public funding opportunity titled "Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Patient-Centered Outcomes Research Findings (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.226,.
- This funding opportunity was created on May 24, 2016 and posted on May 24, 2016.
- Applicants must submit their applications by Jan 25, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Patient-Centered Outcomes Research Findings (R18)" (Funding Opportunity Number PA-16-283) is a discretionary federal research grant offered by the U.S. Department of Health and Human Services through the Agency for Healthcare Research and Quality (HHS-AHRQ). It uses the R18 funding mechanism, which is commonly aimed at applied health services research and demonstration-type projects that can show real-world impact in healthcare delivery.
The core focus of this announcement is not to invent new clinical decision support (CDS) tools from scratch, but to take CDS that is already established, proven effective, and working well in at least one real clinical environment, and then scale it outward so it can be implemented and evaluated in additional settings. In practical terms, the FOA is aimed at spreading decision support functionality embedded in clinical workflows (often through electronic health records or related health IT systems) so that evidence-based findings from Patient-Centered Outcomes Research (PCOR) are more consistently used in everyday care. PCOR findings typically emphasize outcomes and decisions that matter to patients, such as quality of life, functional status, symptom burden, and tradeoffs among treatment options, and this FOA is designed to make those findings easier to apply at the point of care through CDS.
A central purpose of the program is dissemination and implementation: helping move validated research results into routine practice, at scale. The FOA highlights two linked expectations: (1) extending implementation beyond the original institution or clinical site where the CDS was first developed and tested, and (2) evaluating that expanded implementation. That means applicants are expected to show that the CDS is already well-established and effective, then propose a plan to deploy it in new settings (for example, new hospitals, clinics, health systems, or provider networks) while also measuring how well it performs, how well it is adopted, and what impact it has on practice patterns and patient-centered outcomes. The emphasis on evaluation suggests that projects should do more than installation and training; they should also generate usable evidence about what it takes to replicate success across different organizations, populations, workflows, and technical environments.
Funding details in the opportunity include an award ceiling of $500,000. The announcement lists CFDA numbers 93.226 (and also references 93.226 in the provided data), indicating the federal assistance listing associated with AHRQ programs. The instrument type is a grant, and the activity category is health. While the eligibility line is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)," the provided excerpt does not include the full eligibility detail; in many AHRQ FOAs, eligible applicants can include a range of organizations such as universities, health systems, nonprofit organizations, and other research or delivery organizations, but the definitive scope would be in the full FOA eligibility section.
The timeline information in the source data shows the FOA was created and posted on May 24, 2016, with an original and current closing date of January 25, 2018. In other words, it was a time-limited competition with a fixed due date. The entry also lists "ExpectedAwards:" but does not provide a number in the supplied text, so the quantity of awards is not specified in the excerpt.
Overall, this opportunity is best understood as a push to turn already-successful CDS interventions into broadly usable, transportable tools that can help clinicians and patients make better, evidence-aligned decisions across multiple real-world care settings. The intended payoff is wider uptake of patient-centered evidence, stronger consistency in evidence-based practice, and clearer knowledge about the practical requirements, barriers, and enabling factors involved in spreading effective CDS beyond the place where it first proved itself.
Frequently Asked Questions (FAQs)
What is the official title of this grant opportunity?
The opportunity is titled "Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Patient-Centered Outcomes Research Findings (R18)."
What is the funding opportunity number (FON)?
The Funding Opportunity Number is PA-16-283.
Which federal agency is offering this grant?
This is a discretionary federal research grant offered by the U.S. Department of Health and Human Services (HHS) through the Agency for Healthcare Research and Quality (AHRQ), referenced as HHS-AHRQ.
What type of funding instrument is this?
The instrument type is a grant.
What is the funding mechanism used for this opportunity?
The opportunity uses the R18 mechanism, which is commonly used for applied health services research and demonstration-type projects intended to show real-world impact in healthcare delivery.
What is the main purpose of this FOA?
The main purpose is to scale clinical decision support (CDS) that is already established and proven effective in at least one real clinical environment, so it can be implemented and evaluated in additional settings and help disseminate and implement patient-centered outcomes research (PCOR) findings in routine care.
Is this funding meant to create brand-new clinical decision support tools?
No. The core focus is not to invent new CDS tools from scratch, but to take CDS that is already established, effective, and working well in at least one clinical environment and scale it outward to new settings.
What does "clinical decision support (CDS)" mean in the context of this opportunity?
In this context, CDS refers to decision support functionality embedded in clinical workflows, often through electronic health records (EHRs) or related health IT systems, to help apply evidence-based findings at the point of care.
What does the FOA mean by "Patient-Centered Outcomes Research (PCOR) findings"?
PCOR findings typically emphasize outcomes and decisions that matter to patients, such as quality of life, functional status, symptom burden, and tradeoffs among treatment options. This FOA aims to make those findings easier to use in everyday care through CDS.
What is the central focus: dissemination, implementation, or both?
Both. A central purpose is dissemination and implementation, meaning the program is focused on moving validated research results into routine practice at scale, not just producing research outputs.
What are the two linked expectations highlighted in the FOA?
The FOA highlights two linked expectations: (1) extending implementation beyond the original institution or clinical site where the CDS was first developed and tested, and (2) evaluating that expanded implementation.
What does "scaling" mean for applicants under this announcement?
Scaling means taking CDS that has already been shown to work in at least one real-world clinical environment and deploying it in additional settings, such as new hospitals, clinics, health systems, or provider networks.
What kinds of settings are considered "additional settings" for implementation?
The announcement gives examples such as new hospitals, clinics, health systems, or provider networks, indicating implementation beyond the original site where the CDS was first developed and tested.
What is expected in terms of evaluation?
Applicants are expected to evaluate the expanded implementation, including how well the CDS performs, how well it is adopted, and what impact it has on practice patterns and patient-centered outcomes. The evaluation emphasis suggests projects should go beyond installation and training.
Does the opportunity emphasize learning what it takes to replicate success in new environments?
Yes. The FOA emphasizes generating usable evidence about what it takes to replicate success across different organizations, populations, workflows, and technical environments, including practical requirements, barriers, and enabling factors.
What is the award ceiling for this grant opportunity?
The award ceiling listed is $500,000.
What is the activity category for this opportunity?
The activity category is health.
What CFDA number is associated with this funding opportunity?
The announcement lists CFDA number 93.226 (and references 93.226 in the provided data) as the associated federal assistance listing tied to AHRQ programs.
Who is eligible to apply?
The eligibility line is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)." The provided excerpt does not include the full eligibility details, so eligibility cannot be fully confirmed from the information provided here.
Are the number of expected awards specified in the provided information?
No. The entry lists "ExpectedAwards:" but does not provide a number in the supplied text, so the quantity of awards is not specified in the excerpt.
When was this FOA created and posted?
The timeline information shows the FOA was created and posted on May 24, 2016.
What was the application closing date?
The original and current closing date listed is January 25, 2018.
Is this described as a time-limited competition?
Yes. Based on the posted and closing dates provided, it was a time-limited competition with a fixed due date.
What is the overall intended payoff of projects funded under this opportunity?
The intended payoff is wider uptake of patient-centered evidence, stronger consistency in evidence-based practice, and clearer knowledge about the real-world requirements, barriers, and enabling factors involved in spreading effective CDS beyond the original site where it proved itself.
Browse more opportunities from the same category: Health
Next opportunity: ETV+ Media Training
Previous opportunity: Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Resource Cooperative Agreement (U42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 16 283
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 16 283) also looked into and applied for these:
| Funding Opportunity |
|---|
| Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK12 120505CONT16 Funding Number: CDC RFA CK12 120505CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 15050203SUPP16 Funding Number: CDC RFA CK15 15050203SUPP16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Systems Approach to Immunity and Inflammation (U19) Apply for RFA AI 16 050 Funding Number: RFA AI 16 050 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| Limited Interaction Targeted Epidemiology (LITE) to Advance HIV Prevention (UG3/UH3) Apply for RFA AI 16 031 Funding Number: RFA AI 16 031 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| HIV/AIDS Vaccine Facility (C06) Apply for PAR 16 290 Funding Number: PAR 16 290 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) Apply for PA 16 295 Funding Number: PA 16 295 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) Apply for PA 16 296 Funding Number: PA 16 296 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R34) Apply for PAR 16 298 Funding Number: PAR 16 298 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01) Apply for PAR 16 299 Funding Number: PAR 16 299 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| “Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)” TANZANIZ Apply for CDC RFA GH12 123804CONT16 Funding Number: CDC RFA GH12 123804CONT16 Agency: HHS-CDC-CGH Category: Health Funding Amount: Case Dependent |
| Strengthening and the Development of Applied Epidemiology and Sustainable Public Health Capacity through Collaboration, Program development and Implementation, Communication, and Information Sharing in the Eastern Mediterranean Region Apply for CDC RFA GH16 1704 Funding Number: CDC RFA GH16 1704 Agency: HHS-CDC-CGH Category: Health Funding Amount: $4,000,000 |
| Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam Apply for CDC RFA GH16 1718 Funding Number: CDC RFA GH16 1718 Agency: HHS-CDC-CGH Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24) Apply for PAR 16 301 Funding Number: PAR 16 301 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) Apply for PAR 16 300 Funding Number: PAR 16 300 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Programs to Reduce Obesity in High Obesity Areas to Boost Prevention Apply for CDC RFA DP16 1613 Funding Number: CDC RFA DP16 1613 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $800,000 |
| Continuation of Immunization Information Systems (IIS) Sentinel Site Project Apply for CDC RFA IP13 13020401SUPP16 Funding Number: CDC RFA IP13 13020401SUPP16 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: Case Dependent |
| Resilient and Responsive Health Systems (RRHS) Initiative Apply for HRSA 17 007 Funding Number: HRSA 17 007 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Biosensors in the Oral Cavity (R21) Apply for RFA DE 17 005 Funding Number: RFA DE 17 005 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Biosensors in the Oral Cavity (R01) Apply for RFA DE 17 004 Funding Number: RFA DE 17 004 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) Apply for PAR 16 320 Funding Number: PAR 16 320 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 16 283", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.